Journal of Urology

Article	Citations
Urological Oncology: Bladder, Penis and Urethral Cancer, and Basic Principles of Oncology	331
Urological Oncology: Prostate Cancer	229
MP12-03 IL-7 AND CCL19 PRODUCING CAR-T CELLS PREVENT ANTIGEN-LOSS TUMOR RELAPSE AND ENHANCE ANTITUMOR EFFICACY AGAINST SOLID CANCER	226
Editorial Comment	226
MP54-13 THE UPDATE FROM BLADDER CANCER ITALIAN ACTIVE SURVEILLANCE (BIAS) PROJECT FOR LOW-GRADE BLADDER TUMORS: LONG-TERM ONCOLOGICAL OUTCOMES OF PATIENTS UNDER ACTIVE SURVEILLANCE	192
PD40-10 FORMAL VALIDATION AT FINAL PATHOLOGY AFTER RADICAL NEHRECTOMY OF NEPHROMETRY SCORES: DISCORDANCE RATES AND OVERTREATMENT RISK	178
PD23-04 EXPLORING ACTINIDIN AS A NOVEL COLLAGENASE TO TREAT HUMAN PEYRONIE’S DISEASE CELLS	168
MP46-04 10-YEAR EXPERIENCE WITH MIDLINE EXTRAPERITONEAL RETROPERITONEAL LYMPH NODE DISSECTION	162
MP21-16 DEMOGRAPHICS AND INCIDENTAL DIAGNOSES OF MEN WITH PRIAPISM	136
PD35-06 HEALTH-RELATED QUALITY OF LIFE IN LOW-INCOME MEN AFTER SURGICAL CASTRATION FOR METASTATIC PROSTATE CANCER	132
MP21-11 SEVERITY OF PENILE CURVATURE IN PEYRONIE’S DISEASE DOES NOT CORRELATE WITH SHIM OR PDQ SCORES	111
MP40-04 PREDICTIVE RISK FACTORS FOR EARLY RECURRENCE AFTER RADICAL NEPHROURETERECTOMY FOR LOW-GRADE UPPER TRACT UROTHELIAL CARCINOMA	111
This Month in Adult Urology	106
LBA02-02 DEVELOPMENT OF A MULTIPHASIC BLADDER PATCH COMPOSED OF COLLAGEN, AMNIOTIC MEMBRANE, AND PATIENT-DERIVED EPITHELIAL CELLS	102
PD39-05 PROSTATE MEASUREMENT ON COMPUTED TOMOGRAPHY: VARIANCE DECREASES AS PROSTATE VOLUME INCREASES	95
MP11-04 PELVIC ORGAN PROLAPSE IS NOT UNCOMMON AMONG WOMEN WITH SPINA BIFIDA	92
V07-04 SINGLE PORT TRANSVESICAL PARTIAL PROSTATECTOMY FOR LOCALIZED PROSTATE CANCER	90
MP34-01 IS TESTIS SPARING SURGERY A SAFE APPROACH IN PATIENTS WITH SMALL TESTICULAR LESIONS REFERRING TO A FERTILITY CENTER? A RETROSPECTIVE ANALYSIS REPORTING LONG-TERM ONCOLOGICAL OUTCOMES AND FACTO	87
Editorial Comment	82
PD15-05 PROGNOSTIC VALUE OF EARLY DYNAMIC CHANGE OF NEUTROPHIL TO LYMPHOCYTE RATIO (NLR) IN PATIENTS WITH UPPER-TRACT UROTHELIAL CARCINOMA (UTUC) TREATED WITH NEPHROURETERECTOMY	78
PD18-08 PROGNOSTIC VALUE OF NEUTROPHIL-TO-LYMPHOCYTE RATIO AND PLATELET-TO-LYMPHOCYTE RATIO FOR SMALL RENAL CELL CARCINOMAS AFTER IMAGE-GUIDED CRYOABLATION (CRYO) OR RADIO-FREQUENCY ABLATION (RFA)	73
PD23-09 AUXETIC EXPANSION OF THE TUNICA ALBUGINEA FOR PENILE LENGTH AND GIRTH RESTORATION WITHOUT A GRAFT: A CASE SERIES.	63
MP24-01 RACE BASED EQUATIONS FOR ESTIMATING KIDNEY FUNCTION MAY CONTRIBUTE TO RACIAL DISPARITIES IN PARTIAL NEPHRECTOMY UTILIZATION AMONG BLACK PATIENTS WITH KIDNEY TUMORS	61
MP05-16 NEW PERSPECTIVES ON AN OLD GROUPING: THE GENOMIC AND PHENOTYPIC DIFFERENCES OF OXALOBACTER FORMIGENES	61
PD19-03 ASSESSMENT OF FACTORS INVOLVED IN LASER FIBER DEGRADATION WITH THULIUM FIBER LASER	60

MP45-07 ONCOLOGIC OUTCOMES OF TOTAL LENGTH GLEASON PATTERN 4 ON BIOPSY IN MEN WITH GRADE GROUP 2 PROSTATE CANCER	59
MP17-03 COMPLICATION RATES AMONG DIFFERENT TREATMENT MODALITIES FOR THE SURGICAL MANAGEMENT OF VESICOURETERAL REFLUX IN CHILDREN	57
MP58-16 DOES VETERAN STATUS MITIGATE RACIAL DISPARITIES IN PROSTATE CANCER SCREENING? ANALYSIS OF PROSTATE-SPECIFIC ANTIGEN SCREENING PATTERNS IN THE 2018 BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM DA	56
MP56-17 RADICAL CYSTECTOMY VIDEO CONSENSUS: A SIMPLE AND EFFECTIVE WAY TO IMPROVE AWARENESS OF PATIENTS UNDERGOING RADICAL CYSTECTOMY	56
PD55-02 PREDICTION OF CHEMICAL COMPOSITION OF URINARY STONE THROUGH DEEP LEARNING	55
MP14-17 MORTALITY ASSOCIATED WITH SEPSIS POST-URETEROSCOPY AMONG A US-BASED COMMERCIAL POPULATION	55
MP26-09 ACCURACY OF DIAGNOSTIC CODES IN A CLINICAL RESEARCH NETWORK TO IDENTIFY PRIMARY HYPEROXALURIA PATIENTS	54
MP33-09 RADIOGENOMIC CORRELATES OF CLINICALLY RELEVANT CLEAR CELL RENAL CELL CANCER BIOMARKERS	53
PD58-08 SURVIVAL OUTCOMES IN SOLITARY KIDNEY PATIENTS DIAGNOSED WITH UPPER TRACT UROTHELIAL CARCINOMA	53
PD08-02 URINARY DIVERSION FOR INTERSTITIAL CYSTITIS/BLADDER PAIN SYNDROME: PREVALENCE AND PERIOPERATIVE COMPLICATION RATE	53
MP06-18 A GENOMIC URINE ASSAY TO DETECT URINARY TRACT RECURRENCES IN PATIENTS WITH BLADDER CANCER TREATED WITH RADIOTHERAPY	52
MP47-08 SURGICAL DELAY AFTER BIOPSY AND RISK OF UPSTAGING FOR CLINICAL T1A RENAL CELL CARCINOMA	52
MP24-13 IMPACT OF PRIMARY TUMOR SIZE ON CANCER-SPECIFIC AND ALL-CAUSE MORTALITY IN PATIENTS UNDERGOING CYTOREDUCTIVE NEPHRECTOMY FOR METASTATIC RENAL CELL CARCINOMA: ANALYSIS FROM THE INTERNATIONAL MA	51
MP56-19 TRIMODAL THERAPY VERSUS RADICAL CYSTECTOMY FOR T2 BLADDER CANCER: REAL-WORLD EVIDENCE FROM ONTARIO	51
MP11-12 PRENATAL DIAGNOSIS OF BLADDER AND CLOACAL EXSTROPHY OVER 20 YEARS	49
PD41-12 FROM BIOPSY TO DIAGNOSIS IN 30 MIN: REMOTE INSTANT PROSTATE PATHOLOGY BASED ON ARTIFICIAL INTELLIGENCE ENHANCED ULTRASOUND (AI-US)	47
PD53-06 CHANGES IN MOUSE STOOL MICROBIOME WITH EXPOSURE TO BLADDER CARCINOGEN N-BUTYL-N-(4-HYDROXYBUYTL) NITROSAMINE (BBN): LONGITUDINAL ANALYSIS	46
V11-06 DYNAMIC SENTINEL LYMPH NODE BIOPSY FOR PENILE CANCER: ACCURACY IS IN THE TECHNIQUE	44
PD13-01 THE CONTINUING IMPACT OF THE COVID-19 PANDEMIC ON PROSTATE CANCER MANAGEMENT: A POPULATION BASED ANALYSIS	44
PD51-01 CONTEMPORARY SURGICAL OUTCOMES OF RETROPERITONEAL LYMPH NODE DISSECTION FROM THE SEMS TRIAL	41
PD45-02 UROLIFT VERSUS REZUM FOR BENIGN PROSTATIC HYPERPLASIA: A REAL-WORLD SINGLE-INSTITUTION ANALYSIS	40
MP29-04 EFFECT OF SURGEON VOLUME AND FACILITY VOLUME ON OUTCOMES OF BENIGN PROSTATIC HYPERPLASIA SURGERY	40
Editorial Comment	38
Imaging	37
The Journal of Urology® Home Study Course 2022 Volume 207/208	37
MP46-01 COLLABORATIVE RESILIENCE PROGRAM TO ENHANCE QUALITY OF LIFE FOR POST-PENECTOMY PATIENTS: DYADIC COPING PERSPECTIVE	36
Urological Oncology: Testis Cancer and Advances in Oncologic Therapy	34
V10-11 PARTIAL NEPHRECTOMY IN COMPLEX KIDNEY MASSES - TWO APPROACHES WITH THE DAVINCI SINGLE PORT ROBOT	33
LBA02-10 ASSESSING THE RISKS OF A POSITIVE URINE CULTURE IN UNCOMPLICATED RENAL COLIC PATIENTS	33
MP04-08 TRANEXAMIC ACID TO IMPROVE SAME-DAY DISCHARGE RATES AFTER HOLMIUM LASER ENUCLEATION OF THE PROSTATE: A RANDOMIZED, CONTROLLED PROSPECTIVE TRIAL	32
MP40-02 CAN THE PRESENTATION OF UPPER TRACT UROTHELIAL CANCER GUIDE US ON HOW TO IMAGE NON-VISIBLE HAEMATURIA?: A REVIEW OF 10 YEARS	32
Editorial Comment	31
“Bottoms Up!”: A Toast to Reexamining the Debate of Top-Down vs Bottom-Up Approach for the Evaluation of Febrile Urinary Tract Infection	31
Contemporary Outcomes of Patients with Nonmuscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin: Implications for Clinical Trial Design. Reply.	31
Geriatrics	30
MP28-09 IMPACT OF SPIRITUALITY ON QUALITY OF LIFE IN LOW-INCOME MEN WITH PROSTATE CANCER	30
MP59-17 DEVELOPMENT AND INTERNAL VALIDATION OF A PREDICTIVE MODEL FOR RECURRENCE-FREE SURVIVAL IN PTA LOW-GRADE BLADDER CANCER	30
PD18-04 HAZARD OF DEATH IN VON HIPPEL-LINDAU DISEASE PATIENTS DEPENDS ON GENOTYPE AND ONSET AGE AS WELL AS FIRST AFFECTED LESION	29
MP46-05 CHARACTERIZING ONLINE TESTICULAR CANCER DISCUSSIONS WITH QUANTITATIVE THEMATIC ANALYSIS	29
MP06-15 VIRTUAL REALITY IMMERSION FOR REDUCING ANXIETY AND PAIN DURING TRANSPERINEAL PROSTATE BIOPSY: A PROSPECTIVE, RANDOMIZED CLINICAL TRIAL	29
MP09-02 IS IT CLINICALLY AND ONCOLOGICALLY SAFE TO OMIT PROSTATE BIOPSY IN LOW RISK STRATIFIED PATIENTS?	29
PD51-11 CONCOMITANT VS STAGED LYMPHADENECTOMY IN CLINICALLY NODE-POSITIVE PENILE SQUAMOUS CELL CARCINOMA: RECURRENCE PATTERNS AND SURVIVAL OUTCOMES	29
MP27-09 OXYMATRINE IMPROVES ERECTILE FUNCTION THROUGH SUPPRESSION OF INFLAMMATION AND FIBROSIS IN DIABETIC RATS	28
MP40-03 CIRCULATING CHROMOSOME CONFORMATION SIGNATURES ENHANCE THE ACCURACY OF PSA FOR DETECTING PROSTATE CANCER - RESULTS FROM PERFORMANCE OF THE EPISWITCH TM PCA T	28
MP17-14 IDENTIFYING CRIBRIFORM PATTERN IN MPMRI SCANS FROM 3D RECONSTRUCTED RALP SPECIMENS USING DEEP LEARNING	28
MP22-04 MAINTENANCE OF SKELETAL MUSCLES WHEN RECEIVING NEOADJUVANT CHEMOTHERAPY IMPROVES THE PROGNOSIS FOR PATIENTS WITH MUSCLE INVASIVE BLADDER CANCER	27
V02-10 LIMITED RESOURCES IMPROVISED BASKETS FOR PCNL	27
PD33-08 BACTERIAL BIOFILMS FROM INDWELLING SACRAL NEUROMODULATION DEVICES ARE RECONSTITUTABLE IN VITRO AND EXHIBIT DIFFERENTIAL FORMATION BY MATERIAL TYPE	27
MP67-12 FIRST LOOK: LASER SPECKLE IMAGING IS A NOVEL METHOD TO IDENTIFY AND PRESERVE NEUROVASCULAR BUNDLE DURING ROBOTIC ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY	26
PD23-04 URINARY PROTEINS IN THE DIAGNOSIS OF MIXED INTRINSIC SPHINCTER DEFICIENCY AND DETRUSOR OVERACTIVITY IN FEMALE PATIENTS WITH STRESS URINARY INCONTINENCE?	26

PD32-07 RACE MODIFIED ESTIMATED GLOMERULAR FILTRATION RATE UNDERESTIMATES CHRONIC KIDNEY DISEASE PREVALENCE IN AFRICAN-AMERICAN PATIENTS UNDERGOING PARTIAL AND RADICAL NEPHRECTOMY: IMPLICATIONS FOR SU	26
PD27-02  99m TC-PSMA RADIOGUIDED SURGERY USING A DROP-IN GAMMA PROBE IN RADICAL PROSTATECTOMY: INITIAL RESULTS	25
PD08-12 PREDICTORS OF PROGRESSION AND DELAYED INTERVENTION IN SMALL RENAL MASS PATIENTS UNDERGOING ACTIVE SURVEILLANCE WITHOUT HEALTH-RELATED SELECTION BIAS	25
PD12-11 URETHRAL COMPLICATIONS AFTER METOIDIOPLASTY WITH URETHRAL RECONSTRUCTION	25
MP11-08 EXPLORING THE EFFECT OF METASTASIS DIRECTED THERAPY ON PROGRESSION PATTERNS OF PATIENTS WITH POSITIVE 68Ga-PSMA PET/CT AND BIOCHEMICAL RECURRENCE FROM PROSTATE CANCER	25
MP64-20 UNDERSTANDING CLINICAL OUTCOMES IN PATIENTS RENDERED NO EVIDENCE OF DISEASE IN METASTATIC RENAL CELL CARCINOMA	25
V07-07 WIRE-GUIDED EXTRAVESICAL ROBOT-ASSISTED BLADDER DIVERTICULECTOMY AND Y-V PLASTY FOR RECURRENT BLADDER NECK STRICTURE	24
LBA01-08 EFFICACY OF TARGETED MAST CELL INHIBITION THERAPY IN CHRONIC PROSTATITIS/CHRONIC PELVIC PAIN SYNDROME	24
V04-06 ROBOTIC ASSISTED TRANS-VESICOSCOPIC URETERIC REIMPLANTATION IN CHILDREN: SURGICAL ERGONOMICS RELATED TO MUSCULOSKELETAL SYMPTOMS	24
MP53-20 INITIAL UROLOGIC EVALUATION FOR ANORECTAL MALFORMATIONS: A PCPLC RETROSPECTIVE	24
MP28-03 CYTOREDUCTIVE NEPHRECTOMY FOLLOWING IMMUNE CHECKPOINT INHIBITORS IS SAFE AND FACILITATES TREATMENT FREE INTERVALS	24
PD04-08 BALIXAFORTIDE, A CXCR4 INHIBITOR, SYNERGIZES WITH DOCETAXEL TO DIMINISH TUMOR GROWTH IN A PROSTATE CANCER MODEL OF BONE METASTASIS	24
PD43-02 FUNCTIONAL OUTCOMES AFTER SELECTIVE CLAMPING IN ROBOT-ASSISTED PARTIAL NEPHRECTOMY	23
MP38-19 FOCAL THERAPY CANDIDACY: AN EVALUATION OF INITIAL AND CONTINUED ELIGIBILITY FOR FOCAL THERAPY IN AN ACTIVE SURVEILLANCE COHORT	23
PD39-07 CAN WE STOP DOING SYSTEMATIC BIOPSIES IN MEN WITH PIRADS/LIKERT 5 LESIONS ON MULTI PARAMETRIC MAGNETIC RESONANCE IMAGING? AN ANALYSIS FROM A MULTICENTRE PROSPECTIVE DATASET OF OVER 800 PATIENT	23
MP48-04 PERSPECTIVES OF SOCIETY OF WOMEN IN UROLOGY MEMBERS TOWARD DOBBS V. JACKSON WOMEN′S HEALTH ORGANIZATION	23
MP66-14 WEBSITE TRANSPARENCY AND INFORMATION DISSEMINATION AMONG UROLOGY RESIDENCY PROGRAMS	23
PD17-03 REDOX IMBALANCE AND MAPK ACTIVATION MEDIATES PNEUMOPERITONEUM-INDUCED KIDNEY INJURY DURING MINIMALLY INVASIVE SURGERY	22
HF02-04 KEEPING IT REEL: PHOTOGRAPHY AND CINEMATOGRAPHY IN UROLOGY	22
MP57-02 AN UPDATE ON PROFESSIONAL BURNOUT AND CONFLICT-WORK FROM THE AUA WORKFORCE WORKGROUP	22
PD24-03 BEST TREATMENT FOR OLIGOMETASTATIC RENAL CANCER: A QUASI-INDIVIDUAL PATIENT DATA ANALYSIS	21
MP36-05 CLINIC SCORE - A NOVEL PREDICTION MODEL OF COLLAGENASE CLOSTRIDIUM HISTOLYTICUM OUTCOMES IN MEN WITH PEYRONIE’S DISEASE	21
MP07-15 LANGUAGE-RELATED DISPARITIES IN ACUTE POSTOPERATIVE PAIN MANAGEMENT FOLLOWING PELVIC FLOOR RECONSTRUCTIVE SURGERY	21
MP36-04 PREDICTORS OF PENILE PLICATION AFTER INTRALESIONAL COLLAGENASE CLOSTRIDIUM HISTOLYTICUM INJECTION IN MEN WITH PEYRONIE’S DISEASE	21
MP30-02 A NOVEL PREDICTION MODEL FOR POSSIBILITY OF SPERM RETRIEVAL IN MICRO TESE FOR NON-OBSTRUCTIVE AZOOSPERMIA PATIENTS USING AUTOMATED ARTIFICIAL INTELLIGENCE	21
MP12-03 IMPLICATIONS OF RACE FREE RENAL FUNCTION EQUATIONS ON BLACK PATIENTS WITH RENAL CELL CARCINOMA	21
PD14-12 SEXUAL FUNCTION IN WOMEN FOLLOWING TENSION-FREE VAGINAL TAPE-OBTURATOR PROCEDURE: A PROSPECTIVE STUDY	21
MP70-07 HIGH-PERFORMING SCALABLE EXTRACTION OF ELEMENTS OF URINARY TRACT DILATION CLASSIFICATION USING NATURAL LANGUAGE PROCESSING ALGORITHMS FOR NEONATAL ULTRASOUND REPORTS	21
MP62-05 AUA RECOMMENDED ANTIBIOTIC PROPHYLAXIS FOR PRIMARY PENILE IMPLANTATION RESULTS IN A HIGHER, NOT LOWER, RISK FOR POST-OPERATIVE INFECTION: A MULTICENTER ANALYSIS	21
PD19-09 IMMUNOPROPHYLAXIS WITH AUTOVACCINE DECREASES HOSPITAL ADMISSIONS AND EMERGENCY ROOM VISITS IN PATIENTS WITH NEUROGENIC BLADDER	21
MP02-03 FASCIOCUTANEOUS FLAP CLOSURE OF THE PERINEUM AS AN ALTERNATIVE TO SCROTOPLASTY FOR EXTENSIVE GENITAL TISSUE LOSS	21
PD47-12 DOES ANESTHESIA TYPE MATTER IN SHOCKWAVE LITHOTRIPSY?	20
PD31-09 DEVELOPMENT OF EXTREME GRADIENT BOOST (XGBOOST) MACHINE LEARNING MODEL USING AN INSTITUTIONAL PEDIATRIC KIDNEY TRANSPLANT DATABASE FOR PREDICTION OF DELAYED GRAFT FUNCTION	20
PD26-10 COMPARISON OF INTRAVESICAL THERAPY AND SURGERY AS TREATMENT OPTIONS FOR RECURRENT BLADDER CANCER (CISTO): UPDATE ON AN ONGOING MULTICENTER PRAGMATIC STUDY	20
MP41-18 CLINICAL MANIFESTATIONS OF BIRT-HOGG-DUBE SYNDROME IN A LARGE CLINICAL COHORT	20
MP38-07 UPGRADING ON PER PROTOCOL VS FOR CAUSE SURVEILLANCE PROSTATE BIOPSIES: AN OPPORTUNITY TO DECREASING THE BURDEN OF ACTIVE SURVEILLANCE	20
Urologic Heterodoxy Leads to Discovery	19
Editorial Comment	19
Editorial Comment	19
MP15-18 MOLECULAR CHARACTERIZATION OF URETHRAL CANCER AND COMPARISON WITH BLADDER CANCER	19
MP57-13 IS BIPOLAR ENUCLEATION OF THE PROSTATE AN EFFECTIVE AND COST-EFFICIENT ALTERNATIVE TO ROBOTIC SIMPLE PROSTATECTOMY?	19
MP33-08 OPIOID PRESCRIBING PATTERNS AND POST-PROSTATECTOMY READMISSION	19
PD35-04 OPEN VS. ROBOTIC-ASSISTED RECONSTRUCTION IN VESICOURETHRAL ANASTOMOTIC STENOSIS	19
Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology	19
Reply by Authors	19
PD51-08 SREBP1 INDUCES RESISTANCE TO HIF-2α ANTAGONIST IN CLEAR CELL RENAL CELL CARCINOMA	19
MP02-18 APPROPRIATENESS OF IMAGING FOR LOW-RISK PROSTATE CANCER – REAL WORLD DATA FROM THE PENNSYLVANIA UROLOGIC REGIONAL COLLABORATION (PURC)	18
PD61-05 ONCOLOGICAL OUTCOMES OF NEOADJUVANT DEGARELIX WITH APALUTAMIDE (ARNEO TRIAL) VERSUS STANDARD OF CARE PRIOR TO RADICAL PROSTATECTOMY FOR HIGH-RISK PROSTATE CANCER: A PROPENSITY SCORE MATCHED AN	18
MP62-13 LONG-TERM MEDICATION USE AFTER SURGICAL TREATMENT FOR BLADDER OUTLET OBSTRUCTION, HOW DOES HOLEP COMPARE TO OTHER SURGICAL MODALITIES?	18
MP24-16 URETEROSCOPY AT AMBULATORY SURGERY CENTERS CAN BE SAFE FOR CAREFULLY SELECTED HIGH-RISK PATIENTS	18
PD23-09 THE EFFECT OF ADRENALECTOMY ON OVERALL SURVIVAL IN METASTATIC ADRENOCORTICAL CARCINOMA	18
V02-06 A TECHNIQUE FOR COMBINED ROBOTIC SACROCOLPOPEXY AND VENTRAL MESH RECTOPEXY	18
MP01-10 THE LANDSCAPE OF RACIAL AND ETHNIC DISPARITY IN TESTICULAR CANCER STAGE PRESENTATION: A NATIONAL HOSPITAL-BASED STUDY	18
PD47-07 THE STUDY OF AUTOMATIC RECOGNITION OF STONE COMPONENTS USING DIGITAL IMAGES FROM INTRAOPERATIVE FLEXIBLE URETEROSCOPY	18
MP13-02 PATTERNS OF TELE-HEALTH USAGE AFTER THE COVID-19 PANDEMIC AMONG SURGICAL SPECIALTIES AND UROLOGY	18
PD58-09 GROWTH KINETICS OF ONCOCYTIC NEOPLASMS ON ACTIVE SURVEILLANCE AND IMPACT ON RENAL FUNCTION	18
MP76-14 PROPHYLACTIC DIPS AND IRRIGATION SOLUTIONS CAN CONSIDERABLY ALTER THE ANTIMICROBIAL EFFICACY OF INFLATABLE PENILE PROSTHESIS HYDROPHILIC SURFACE COATINGS	18
MP02-01 "DOCTOR 1 PUT ME IN TOUCH WITH A FORMER PATIENT... OF MY EXPERIENCE THROUGH IT, I THINK SHE HELPED ME THE MOST": PEER SUPPORT AS AN INVALUABLE RESOURCE IN THE SETTING OF BLADDER CANCER SURGERY	18
MP31-07 PROSTATE EXTRACELLULAR VESICLES AND PREDICTION OF CLINICALLY SIGNIFICANT PROSTATE CANCER: A PROSPECTIVE SINGLE-INSTITUTION PILOT STUDY	17
PD14-08 IDENTIFICATION OF A BLADDER CANCER SUBPOPULATION THAT MAY BENEFIT FROM DASATINIB	17
MP34-14 ASSOCIATION OF POPULATION-LEVEL SOCIAL DETERMINANTS OF HEALTH WITH UROLOGIC CANCER CLINICAL TRIALS AVAILABILITY	17
MP32-17 LONG-TERM FOLLOW-UP AND SUCCESS RATE OF VENTRAL INLAY BUCCAL MUCOSAL GRAFT URETHROPLASTY VS DORSAL ONLAY BUCCAL MUCOSAL GRAFT URETHROPLASTY FOR FEMALE URETHRAL STRICTURE DISEASE	17
MP08-20 SIGNIFICANT DROP OF EARLY AND TWO-YR MORTALITY FOR BLADDER CANCER PATIENTS RECEIVING RADICAL CYSTECTOMY IN THE LAST 20 YEARS: SINGLE CENTER ANALYSIS	17
PD27-01 DEVELOPMENT OF A MACHINE LEARNING (ML) MODEL TO AUTOMATICALLY AND PRECISELY IDENTIFY KIDNEY STONES FROM URETEROSCOPY VIDEO RECORDINGS	16
PD28-08 ASSOCIATION OF LOW TESTOSTERONE, FRAILTY, AND POSTOPERATIVE OUTCOMES AMONG MEN UNDERGOING UROLOGIC SURGERY	16
MP19-05 LEARNING CURVES OF FUSION-GUIDED BIOPSY AND ULTRASOUND PROSTATE SEGMENTATION: A SINGLE-CENTER STUDY INVOLVING 14 OPERATORS AND 1721 PATIENTS	16
MP69-05 DEVELOPING AN ANTIMICROBIAL IRRIGATION SOLUTION FOR ENDOUROLOGICAL PROCEDURES: EX VIVO EFFICACY AND IN VIVO SAFETY	16
V11-11 HUGO RAS SIMPLE PROSTATECTOMY SEC. MILLIN: STEP BY STEP SURGICAL PROCEDURE AND SET UP IN A THREE ARMS CONFIGURATION	16
MP21-06 USABILITY TESTING OF THE SET BRAVE GOALS APP, A CONTINENCE GOAL-SELECTION APP FOR CHILDREN WITH SPINA BIFIDA	16
PD61-12 SAME-DAY DISCHARGE FOLLOWING ROBOTIC PROSTATECTOMY: STANDARDIZATION AND SAFETY EVALUATION	16
MP36-11 GERIATRIC NUTRITIONAL RISK INDEX AS A SIGNIFICANT PROGNOSTIC FACTOR IN PATIENTS WITH CLEAR-CELL RENAL CELL CARCINOMA	16
MP44-05 PARENCHYMAL VOLUME ANALYSIS TO ASSESS LONGITUDINAL FUNCTIONAL DECLINE AND ATROPHY AFTER PN	16
PD31-06 LONG-TERM OUTCOMES AFTER ISOLATED EPISPADIAS REPAIR	16
MP43-19 NOVEL NANOPARTICLE COATINGS DEMONSTRATE ANTIBACTERIAL AND ANTIBIOFILM PROPERTIES AGAINST MULTIPLE UROPATHOGENS	16
PD49-07 UTILITY OF TESTICULAR SHEAR-WAVE ELASTOGRAPHY IN THE EVALUATION OF PEDIATRIC PATIENTS WITH KLINEFELTER SYNDROME	16
MP76-02 EXPLORING THE EFFECTS OF AMNIOTIC BLADDER THERAPY ON FEMALE SEXUAL DYSFUNCTION IN INTERSTITIAL CYSTITIS/BLADDER PAIN SYNDROME PATIENTS	16
PD55-09 THE BALL IS OUT OF OUR COURT: DOES MODERN PRIMARY CARE LITERATURE REFLECT THE AMERICAN UROLOGICAL ASSOCIATION CRYPTORCHIDISM GUIDELINES?	16
MP35-13 PREVALENCE, TRENDS, AND COSTS OF OFFICE-BASED AND AMBULATORY SURGERY CENTER-BASED DIAGNOSTIC CYSTOSCOPY IN THE UNITED STATES	16
PD28-11 O TO ZZZ's: INVESTIGATING THE RELATIONSHIP BETWEEN ORGASM AND SLEEP QUALITY IN WOMEN	16
PD43-11 SOCIODEMOGRAPHIC FACTORS AND FRAILTY IMPACT ADVANCED THERAPY UTILIZATION AMONG MEDICARE BENEFICIARIES	16

PD58-01 PREVALENCE AND SPECTRUM OF GERMLINE MUTATIONS IN PATIENTS WITH UPPER TRACT UROTHELIAL CARCINOMA	16
PD52-01 A PHASE 2 RANDOMIZED, PLACEBO-CONTROLLED CROSSOVER TRIAL TO EVALUATE SAFETY AND EFFICACY OF PLATELET-RICH PLASMA INJECTIONS FOR PEYRONIE'S DISEASE: CLINICAL TRIAL UPDATE	16
MP03-13 ARTIFICIAL URETHRAL SPHINCTER PRESSURE REGULATING BALLOON AND CUFF VARIATIONS FOLLOWING DEVICE EXPLANTATION	16
MP63-07 THE BUTOX STUDY: THE ROLE OF THE GUT MICROBIOME AND BUTYRATE IN CALCIUM OXALATE KIDNEY STONE DISEASE	16
MP70-20 MORTALITY DISPARITIES AMONG ASIAN AMERICANS DIAGNOSED WITH UROLOGIC CANCER	16
MP54-17 FOSTERING DIVERSITY IN UROLOGY: ADDRESSING ETHNIC DISPARITIES IN APPLICANT AND RESIDENT RECRUITMENT	15
MP69-07 UROLOGIC COMPLICATIONS OF SODIUM-GLUCOSE CO-TRANSPORTER-2 (SGLT-2) INHIBITORS DIFFER BETWEEN DIABETIC MEN AND WOMEN	15
MP09-01 TEMPORAL TRENDS OF BPH MEDICATIONS AND PROCEDURES - CONTEMPORARY MEDICARE DATABASE ANALYSIS FROM 2013-2020	15
PD18-09 THE ROLE OF CYTOREDUCTIVE NEPHRECTOMY IN CONTEMPORARY METASTATIC RENAL CELL CARCINOMA: AN OTHER-CAUSE MORTALITY MATCH POPULATION-BASED STUDY	15
MP26-04 HOW MIRABEGRON AFFECTS THE HUMAN URETER: AN IN VITRO STUDY	15
PD33-09 PATHOLOGIC DOWN STAGING WITH NEOADJUVANT CHEMOTHERAPY AS A PREDICTOR OF ONCOLOGICAL OUTCOMES FOR UPPER TRACT UROTHELIAL CARCINOMA TREATED WITH NEPHROURETERECTOMY: A ROBUUST REGISTRY ANALYSIS	15
PD33-10 ROBOT-ASSISTED PARTIAL NEPHRECTOMY WITH HUGO™ RAS SYSTEM: PERIOPERATIVE OUTCOMES AND TRIFECTA ACHIEVEMENT FROM THE LARGEST MULTICENTRIC SERIES	15
PD14-05 THE STROMA-RICH CONSENSUS BLADDER CANCER SUBTYPE CORRELATES WITH IMPROVED PROGNOSIS AFTER NEOADJUVANT IMMUNOTHERAPY AND RADICAL CYSTECTOMY	15
PD14-10 ENHANCED ANTITUMOR EFFECT OF THE COMBINATION OF BACILLE CALMETTE-GUÉRIN AND AN IMMUNE CHECKPOINT INHIBITOR IN BLADDER CANCER-ON-A-CHIP	15
MP29-20 A PROSPECTIVE, SINGLE CENTER RANDOMISED CONTROLLED TRIAL COMPARING DUSTING AND FRAGMENTATION MODES OF THULIUM FIBER LASER IN RETROGRADE INTRARENAL SURGERY	15
MP36-19 DEVELOPMENT AND VALIDATION OF A NOVEL NOMOGRAM TO PREDICT LYMPH NODE INVASION IN UPPER TRACT UROTHELIAL CARCINOMA	15
PD55-04 IS PERCUTANEOUS NEPHROLITHOTOMY EFFECTIVE AND SAFE IN INFANTS YOUNGER THAN 2 YEARS OLD? COMPARISON OF MINI AND STANDARD PERCUTANEOUS NEPHROLITHOTOMY?	15
V14-05 ARTIFICIAL INTELLIGENCE-BASED INTRAOPERATIVE GUIDANCE: DEMONSTRATION OF REAL-TIME SEGMENTATION AND FEATURE TRACKING IN ROBOTIC SURGERY	14
MP18-02 DOES DEEP LEARNING RECONSTRUCTION IMPROVE URETERAL STONE DETECTION AND SUBJECTIVE IMAGE QUALITY IN THE CT IMAGES OF PATIENTS WITH METAL HARDWARE?	14
MP46-13 ROBOT-ASSISTED RADICAL CYSTECTOMY WITH INTRACORPOREAL PADUA ILEAL NEOBLADDER: LONG-TERM FUNCTIONAL OUTCOMES AND CONTINENCE PREDICTORS ASSESSMENT FROM A HIGH-VOLUME CENTER LARGE CONSECUTIVE SER	14
MP15-10 DISCOVERY OF TBK1 ASSOCIATED ONCOGENIC MECHANISM WHICH MEDIATES THE UPPER-TRACT UROTHELIAL CARCINOMA WITH PREEXISTING END STAGE RENAL DISEASE	14
MP39-14 EVALUATING THE CONTRIBUTION OF THE STANDARDIZED LETTER OF RECOMMENDATION TO A SUCCESSFUL MATCH IN UROLOGY RESIDENCY	14
MP41-11 CIRCULATING MICRORNA PROFILING FOR PREDICTION OF ONCOLOGICAL OUTCOMES IN PROSTATE CANCER PATIENTS FOLLOWING RADICAL PROSTATECTOMY	14
PD30-07 HIGH-GRADE TA NON-MUSCLE INVASIVE BLADDER CANCER DEMONSTRATES HOMOGENEOUS ONCOLOGICAL OUTCOMES REGARDLESS OF EAU 2021 RISK GROUP STRATIFICATION	14
MP70-06 MATCHED ANALYSIS OF URINARY TRACT INFECTIONS AND READMISSIONS AFTER OPEN URETERONEOCYSTOSTOMY: DOES AGE MATTER?	14
V08-03 ENDOSCOPIC RESECTION OF AN ENTEROANASTOMOTIC TUMOR RECURRENCE AFTER RADICAL CYSTECTOMY: A NOVEL APPROACH USING BIPOLAR RESECTION	14
MP49-07 DEFINING HIGH GLEASON SCORE PROSTATE CANCER BY PROSTATE FLUID METABOLIC FINGERPRINT BASED MULTI-MODAL DIAGNOSIS	14
PD05-03 REDUCING EMERGENCY ROOM VISITS THROUGH THE USE OF MULTI-LANGUAGE EDUCATIONAL PAMPHLETS AFTER URETEROSCOPY WITH URETERAL STENT PLACEMENT	14
MP30-15 MACHINE LEARNING TO DISTINGUISH BENIGN AND MALIGNANT RENAL LESIONS BASED ON ROUTINE CT IMAGING	14
PD41-11 THE IMPACT OF PROSTATE VOLUMES (≤80 CC VS. > 80 CC) ON PERIOPERATIVE OUTCOMES AND RISK OF RETREATMENT IN PATIENTS UNDERGOING AQUABLATION: A SINGLE-CENTER STUDY	14
PD15-04 PREDICTION OF PROSTATE CANCER SPECIFIC MORTALITY IN MEN UNDERGOING RADIOTHERAPY WITH OR WITHOUT HORMONAL TREATMENT, RISK STRATIFICATION BASED ON CLINICAL CHARACTERISTICS AND PSA TREATMENT RESP	14
MP75-17 EXAMINING THE RELATIONSHIP BETWEEN DIETARY INFLAMMATORY INDEX AND URINARY FLOW RATE: RESULTS FROM A NATIONWIDE STUDY	14
Precision-guidance vs Systematic Sampling: Optimizing Biopsy Assessment of Secondary Prostate Cancer Suspicious Multiparametric Magnetic Resonance Imaging Lesions	14
PD18-04 SURVIVAL IS DRAMATICALLY IMPROVED FOR MRCC PATIENTS WITH SARCOMATOID FEATURES WHO ARE TREATED WITH CYTOREDUCTIVE NEPHRECTOMY AND IMMUNE CHECKPOINT INHIBITORS REGARDLESS OF TREATMENT SEQUENCE	14
PD25-05 CHRONIC EXPOSURE OF PHYSIOLOGICAL CONCENTRATION OF ARSENIC INDUCED BLADDER MALIGNANCY IN PRECLINICAL MODELS	13
MP47-03 TRENDS IN SBRT FOR INOPERABLE RENAL CELL CARCINOMA	13
PD10-10 IMPROVING PREDICTION OF LOCAL STAGE BY PSMA-PET. DEVELOPMENT OF A NOVEL INTEGRATED TOOL FOR EXTRACAPSULAR EXTENSION AND SEMINAL VESICLE INVASION COMBINING CLINICAL AND IMAGING FEATURES IN LOCA	13
MP35-11 TRENDS AND INCIDENCE OF REPORTED EVENTS ASSOCIATED WITH URETERAL STENTS: AN ANALYSIS OF THE FOOD AND DRUG ADMINISTRATION'S MANUFACTURER AND USER FACILITY DEVICE EXPERIENCE DATABASE	13
MP15-09 TADALAFIL VERSUS COMBINED TAMSOLUSIN AND CIPROFLOXACIN FOR TREATMENT OF CHRONIC PELVIC PAIN SYNDROME: A RANDOMIZED CONTROLLED TRIAL	13
MP61-11 RETZIUS-SPARING ROBOT-ASSISTED RADICAL PROSTATECTOMY AFTER PREVIOUS TRANS-URETHRAL RESECTION OF THE PROSTATE: ASSESSMENT OF FUNCTIONAL AND ONCOLOGICAL OUTCOMES	13
MP79-10 PHARMACOVIGILANCE ANALYSIS OF MELANOMA ADVERSE EVENTS IN MEN TREATED WITH SILDENAFIL FOR ERECTILE DYSFUNCTION	13
MP44-08 RELATIONSHIP BETWEEN COVID 19 VACCINATION AND PSA LEVEL	13
PD08-11 ACTIVE SURVEILLANCE VERSUS PRIMARY INTERVENTION FOR CLINICAL T1a KIDNEY TUMORS: TWELVE-YEAR EXPERIENCE OF THE DISSRM PROSPECTIVE COMPARATIVE STUDY	13
MP72-17 SURGEON’S PERSONAL OPIOID BEHAVIORS IMPACT POST-OPERATIVE PRESCRIBING FOR OUTPATIENT PROCEDURES	13
PD45-03 FACTORS AFFECTING HOLMIUM LASER INEFFICIENCY: COMPARISON OF LARYNGEAL MASK AIRWAY AND ENDOTRACHEAL TUBE USE DURING FLEXIBLE URETEROSCOPY FOR RENAL STONES	13
MP72-09 SELF-SCHEDULING IMPROVES QUALITY OF CARE FOR HOSPITAL DISCHARGE FOLLOW UP OF URINARY RETENTION PATIENTS	13
MP25-06 DEVELOPMENT OF A MULTI-INSTITUTIONAL, SIMULATION-BASED SURGICAL SKILLS BOOTCAMP FOR JUNIOR UROLOGY RESIDENTS	13
MP71-18 PERIPHERAL TIBIAL NERVE STIMULATION DEMONSTRATES LIMITED IMPROVEMENT IN SELF-REPORTED SYMPTOMS FOR PATIENTS WITH OVERACTIVE BLADDER: SINGLE CENTER EXPERIENCE	13
MP05-01 MICRO COMPUTED TOMOGRAPHY ANALYSIS OF MINERAL IN RENAL PAPILLAE SHOWS THAT RANDALL'S PLAQUE FORMATION OCCURS INDEPENDENTLY OF UPSTREAM DUCTAL PLUGGING IN THE MEDULLA	13
MP74-18 DETRUSOR VOIDING CONTRACTION VELOCITY IS RELEVANT TO PATIENTS WITHOUT BLADDER OUTFLOW OBSTRUCTION	13
Robotic Urologic Oncologic Surgery: Ever-Widening Horizons	12
Editorial Comment	12
Hooman Djaladat, MD, MS	12
Health-related Quality of Life After Robotic-assisted vs Open Radical Cystectomy: Analysis of a Randomized Trial	12
Pro: Does COVID Affect Male Reproductive Health?	12
MP75-10 SURVIVAL OUTCOMES BY RACE FOLLOWING MINIMALLY INVASIVE SURGICAL TREATMENT FOR UPPER TRACT UROTHELIAL CARCINOMA: AN ANALYSIS OF THE ROBUUST REGISTRY	12
MP58-04 PROPOSAL AND INTERNAL VALIDATION OF A NOMOGRAM FOR THE PREDICTION OF LOCAL RECURRENCE FREE-SURVIVAL AFTER PERCUTANEOUS ABLATION FOR CT1 RENAL MASSES	12
MP20-07 NPTX1 IS A NOVEL SERUM BIOMARKER INDUCED BY ARPI TREATED PROSTATE CANCER AND ENRICHED IN LINEAGE PLASTICITY WITH BRN2 HIGH	12
MP11-16 PROSTATE-SPECIFIC ANTIGEN ANALYSES IN PROPEL: ABIRATERONE AND OLAPARIB VERSUS ABIRATERONE AND PLACEBO AS FIRST-LINE THERAPY FOR METASTATIC CASTRATION-RESISTANT PROSTATE CANCER	12
Male Infertility	12
MP09-16 INFORMING AN APPROACH TO THE SUBCAPSULAR RENAL HEMATOMA (SRH): A TEN-YEAR REVIEW OF THE NATURAL HISTORY AND PROGRESSION OF SRH	12
Genital Hypoplasia in Gender-affirming Vaginoplasty: Prior Orchiectomy, Penile Length, and Other Factors to Guide Surgical Planning	12
PD36-05 DEEP LEARNING PREDICTIVE MODEL FOR PROSTATE CANCER RECURRENCE USING CLINICAL AND HISTOLOGICAL DATA FROM THE TCGA DATABASE	12
PD26-04 A RANDOMIZED STUDY TO COMPARE OUTCOMES OF INTRAVESICAL CHEMOHYPERTHERMIA WITH MITOMYCIN C VS INTRAVESICAL BCG FOR INTERMEDIATE AND HIGH RISK NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC)	12
Food Sensitivities in a Diverse Nationwide Cohort of Veterans With Interstitial Cystitis/Bladder Pain Syndrome	12
PD24-07 FIRST ANALYSIS OF THE SAFETY AND EFFICACY OF UGN-101 IN THE TREATMENT OF URETERAL TUMORS	12
MP53-05 RISK OF ACUTE KIDNEY INJURY AFTER LOWER URINARY TRACT RECONSTRUCTION WITH EARLY NSAID THERAPY: A PROPENSITY MATCHED RETROSPECTIVE ANALYSIS	12
MP03-19 ROLE OF MICROFIBRILLAR-ASSOCIATED PROTEIN 4 IN PARTIAL BLADDER OUTFLOW OBSTRUCTION-RELATED BLADDER FIBROSIS	12
Comparative Outcomes of Salvage Retzius-Sparing versus Standard Robotic Prostatectomy: An International, Multi-Surgeon Series	12
Editorial Comment	12
First Series Using Ultrasonic Propulsion and Burst Wave Lithotripsy to Treat Ureteral Stones	12
FINAL RESULTS: BOND-003 COHORT C- PHASE 3, SINGLE-ARM STUDY OF INTRAVESICAL CRETOSTIMOGENE GRENADENOREPVEC FOR HIGH-RISK BCG-UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER WITH CARCINOMA IN SITU	12
Remission and Transition of Female Urinary Incontinence and Its Subtypes and the Impact of Body Mass Index on This Progression: A Nationwide Population-Based 4-Year Longitudinal Study in China	12
IP23-07 ANATOMY OF A COMPLICATION: CLINICO-RADIOLOGIC FEATURES OF BLEEDINGS AFTER ROBOTIC-ASSISTED RADICAL PROSTATECTOMY. THE ROLE OF THE OBTURATOR ARTERY VARIANTS	12
HF02-14 HERNIAS, HEALING, HAGIOGRAPHY: AN ANALYSIS OF ST. ARTEMIOS AND BYZANTINE INCUBATION RITUALS	12
LBA02-12 IS LEARNING CURVE IMPORTANT WHILE PERFORMING PSMA-PET? ANALYSIS OF DETECTION RATE ACCORDING TO GLEASON SCORE AND PSA LEVEL IN TWO TIMEFRAMES AT A BRAZILIAN HIGH-VOLUME CENTER	12
MP06-20 SIGNIFICANT REDUCTION OF PERIOPERATIVE SERIOUS REPORTABLE EVENTS THROUGH A NOVEL SURGICAL SAFETY CHECKLIST AND TIME-OUT PROCEDURE	12
Extensive Alteration of Androgen Precursor Levels After Castration in Prostate Cancer Patients and Their Association With Active Androgen Level	12
Editorial Comment	11
Comparing Patient-reported Functional Outcomes After Radical Prostatectomy in Historical and Contemporary Practice	11
Editorial Comment	11
Socioeconomic Factors, Urological Epidemiology, and Practice Patterns	11
Infertility: Epidemiology & Evaluation II (PD18)	11
Male and Female Sexual Function and Dysfunction; Andrology	11
Surgical Technology & Simulation: Instrumentation & Technology (IP11)	11
Editorial Comment	11
This Month in Adult Urology	11
Editorial Comment	11
Bladder Cancer: Invasive VI (MP77)	11
Health Services Research: Practice Patterns, Quality of Life and Shared Decision Making II (MP09)	11
Editorial Comment	11
Imaging	11
Size Matters, at Least Sometimes…	11
Urodynamics/Lower Urinary Tract Dysfunction/Female Pelvic Medicine: Pelvic Prolapse (PD44)	11
Prostate Cancer: Localized: Active Surveillance (MP38)	11